tiprankstipranks
Inhibrx Biosciences, Inc. (INBX)
NASDAQ:INBX
US Market

Compare Inhibrx Biosciences Inc (INBX) vs. Competitors

58 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Inhibrx Biosciences Inc
$85.32
$1.10B
564.93%
1 Buy
0 Hold
0 Sell
Moderate Buy
Prothena
$10.50
$565.25M
-2.11
8.36%
2 Buy
1 Hold
1 Sell
Hold
CytomX Therapeutics
$4.39
$949.02M
-33.83
788.66%
9 Buy
0 Hold
0 Sell
Strong Buy
Humacyte
$0.64
$143.29M
-3.72
-58.92%
5 Buy
1 Hold
0 Sell
Strong Buy
Monte Rosa Therapeutics
$17.48
$1.40B
-33.72
321.20%
7 Buy
0 Hold
0 Sell
Strong Buy
Candel Therapeutics
$4.80
$353.78M
-7.84
1.26%
4 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
INBX
Inhibrx Biosciences Inc
75.27
63.66
548.32%
PRTA
Prothena
10.50
0.28
2.74%
CTMX
CytomX Therapeutics
4.39
3.86
725.19%
HUMA
Humacyte
0.65
-0.89
-57.84%
GLUE
Monte Rosa Therapeutics
17.48
13.26
314.22%
CADL
Candel Therapeutics
4.83
-0.14
-2.82%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts